Meyer J C, Burri C, Ruf P, Schnyder U W
Department of Dermatology, University Hospital, Zürich, Switzerland.
Dermatologica. 1989;178(1):29-32. doi: 10.1159/000248382.
In the present study we intended to obtain information on the evolution of near-peak blood levels during long-term treatment. 56 patients with an indication for systemic treatment of nail or skin mycoses obtained a daily dose of 200 mg ketoconazole. They were periodically checked for blood level of ketoconazole, clinical and mycological status and enzyme values. The average blood level was 2.8 +/- 1.3 micrograms/ml plasma. The blood level was not influenced by the length of the treatment. A correlation between blood level and weight or sex was not observed, whereas a significant negative correlation occurred between blood level and age (age group 15-30 years: 3.9 +/- 1.3 micrograms/ml; 46-60 years: 2.4 +/- 0.9 micrograms/ml).
在本研究中,我们旨在获取长期治疗期间接近峰值血药浓度变化的信息。56例有指征接受指甲或皮肤真菌病全身治疗的患者每日服用200mg酮康唑。定期检查他们的酮康唑血药浓度、临床和真菌学状况以及酶值。平均血药浓度为2.8±1.3μg/ml血浆。血药浓度不受治疗时长的影响。未观察到血药浓度与体重或性别之间存在相关性,然而血药浓度与年龄之间存在显著负相关(15 - 30岁年龄组:3.9±1.3μg/ml;46 - 60岁年龄组:2.4±0.9μg/ml)。